MODIFICATION
A -- Clinical Studies Network (CSN) Clinical Trial Planning and Execution (CTPE) - Amendment 2
- Notice Date
- 10/8/2019
- Notice Type
- Modification/Amendment
- NAICS
- 541714
— Research and Development in Biotechnology (except Nanobiotechnology)
- Contracting Office
- Department of Health and Human Services, Office of the Secretary, Acquisitions Management, Contracts, & Grants (AMCG), Office of the Assistant Secretary for Preparedness & Response (ASPR), Department of Health and Human Services, 330 Independence Ave. SW, G640, Washington, District of Columbia, 20201, United States
- ZIP Code
- 20201
- Solicitation Number
- 75A50119R00026
- Response Due
- 10/21/2019 12:00:00 PM
- Point of Contact
- Jeffrey E. Brown, Phone: 2027308662, Enrique Manan,
- E-Mail Address
-
jeffrey.brown@hhs.gov, enrique.manan@hhs.gov
(jeffrey.brown@hhs.gov, enrique.manan@hhs.gov)
- Small Business Set-Aside
- N/A
- Description
- Amendment 2 AMENDMENT 2: To answer question #12 from Amendment 1.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/OOS/OASPHEP/75A50119R00026/listing.html)
- Record
- SN05470401-W 20191010/191008230452-d8f5374af9de2241b9bc7f15e36ffde5 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |